All data are based on the daily closing price as of May 7, 2026
i
Ildong Pharmaceutical
249420.KO
16.44 USD
-0.60
-3.52%
Overview
Last close
16.44 usd
Market cap
517.89M usd
52 week high
30.05 usd
52 week low
7.11 usd
Target price
31.01 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.3116
Price/Book Value
3.318
Enterprise Value
618.25M usd
EV/Revenue
1.5824
EV/EBITDA
13.4896
Key financials
Revenue TTM
390.71M usd
Gross Profit TTM
151.33M usd
EBITDA TTM
27.50M usd
Earnings per Share
N/A usd
Dividend
0.14 usd
Total assets
397.19M usd
Net debt
37.27M usd
About
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provides raw material drugs; health foods and foods; beverages; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. The company was founded in 1941 and is headquartered in Seoul, South Korea.